1
项与 Human Umbilical Cord Mesenchymal Stem Cells(Army Medical Center) 相关的临床试验Clinical Study on Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Sepsis
The primary objective: To evaluate the efficacy of intravenous infusion of universal UC-MSCs and CD83+MSCs subpopulation injection in the treatment of sepsis by using the 28-day survival rate of the subjects as the primary efficacy criterion.The secondary objectives: 1. To systematically evaluate the safety of universal UC-MSCs and CD83+MSCs subpopulation in the treatment of sepsis; 2. To provide theoretical basis and clinical research data for establishing a safe, effective and feasible clinical treatment plan for sepsis using stem cells.
100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Army Medical Center) 相关的临床结果
100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Army Medical Center) 相关的转化医学
100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Army Medical Center) 相关的专利(医药)
100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Army Medical Center) 相关的药物交易